unknown
Stage
About
Cypre develops a 3D tumor organoid platform using proprietary hydrogel technology to create human-derived tumor models that integrate tumor, stromal, and immune compartments for improving cancer drug development and translational research.
Explore Cypre's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.